Skip to main content
. 2017 Dec 20;8:292. doi: 10.3389/fpsyt.2017.00292

Figure 1.

Figure 1

Differences in research domain criteria (RDoC) negative valence system loss across d-amino acid oxidase activator (DAOA) rs746187 genotypes. Differences in Calgary Depression Scale for Schizophrenia (CDSS) item 2: hopelessness scale across DAOA rs746187 genotypes in genotype (A), dominant (B), and recessive (C) model at baseline and last-available follow-up time point until 36 months. Data are presented as mean ± SEM; #0.008 < p < 0.05 (significant without Bonferroni correction).